Robert (Rob) Freedman is co-chair of the Securities & Corporate Finance group and provides corporate and securities law services to late stage and public technology and life sciences companies. He leads initial public offerings and follow-on offerings of equity and debt, and focuses on advising boards and management on corporate and securities law compliance and disclosure matters. Rob has represented issuers and underwriters in securities offerings by public companies for over 20 years. Rob also concentrates on mergers and acquisitions and private financings for public companies.

Rob has been recommended by The Legal 500 for his individual practice and role as co-chair of Fenwick & West’s corporate and securities practice, which was recognized as a team of “highly knowledgeable and flexible technology sector specialists.”

Representative Initial Public Offering Experience:

Aeglea BioTherapeutics
AnaptysBio
Audentes Therapeutics
Castlight Health
Corium International
Cowen and Company
Dermira
DexCom
Loxo Oncology
Piper Jaffray & Co.
ServiceNow
Shutterfly
Sierra Onocology
Silver Spring Networks
Sutro Biopharma
Upwork

Representative M&A and Tender Offer Experience:

OncoGenex Pharmaceuticals’ merger with Achieve Life Science
Castlight Health’s acquisition of Jiff
Corium’s acquisition by Gurnet Point Capital
KalVista Pharmaceuticals’ acquisition of Carbylan Therapeutics
DexCom’s acquisition of SweetSpot Diabetes Care
Zappos.com’s acquisition by Amazon.com
Alpha Innotech’s acquisition by Cell Biosciences
Data Domain’s acquisition by EMC
Cisco Systems’ acquisition of WebEx Communications
Macromedia’s merger with Adobe

Rob is a member of the State Bars of California, Idaho and Washington. He received his A.B. degree in biochemistry and history in 1987 from Bowdoin College where he graduated summa cum laude and Phi Beta Kappa. He received his J.D. degree, with distinction, in 1993 from Stanford University.

Rob is the co-chair for the Practising Law Institute’s “How to Prepare an Initial Public Offering” program. Prior to law school, Rob was a banker for Manufacturers Hanover Trust in New York.